Research Article
BibTex RIS Cite

Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Öğrencilerinin Botulinum Toksini Hakkında Bilgi Düzeyleri: Anket Çalışması

Year 2022, , 336 - 346, 14.03.2022
https://doi.org/10.20515/otd.951150

Abstract

Tıpta kullanımı çok yaygın olan Botulinum toksininin tıp fakültesi öğrencileri arasında bilinirlik ve farkındalık düzeyinin bir anket çalışması üzerinden değerlendirilmesi planlanmıştır. Anket sonunda her sorunun doğru yanıtı/yanıtları açıklanmış olup, öğrencilere gerekli bilgiler verilerek bu konuda daha fazlasını öğrenmeye teşvik etmek amaçlanmıştır. Çalışma 2020-2021 öğretim yılı içinde Osmangazi Tıp Fakültesi öğrencilerine Google anket yöntemi uygulanarak gerçekleştirilmiş kesitsel tanımlayıcı bir çalışmadır. Ankete yanıt veren 404 öğrencinin 53’ü 1. sınıf, 103’ü 2. sınıf, 50’si 3. sınıf, 64’ü 4. sınıf, 68’i 5. sınıf ve 68’i de 6. sınıf öğrencisidir. Sekiz soruluk bu anket çalışmasında her sorunun doğru yanıtı 10 puan olarak belirlenmiş; anket, toplamda 80 puan üzerinden değerlendirilmiştir. Birden fazla doğru yanıtı olan sorularda sorunun değeri doğru yanıt sayısına bölünerek; her bir doğru şıkkın ağırlık puanı hesaplanmıştır. Puan ortalamaları birinci sınıf öğrencilerinden başlayarak sırasıyla 38,87; 41,21; 56,75; 56,59; 60,66 ve 62,95 olarak hesaplanmıştır. Sınıfla beraber Botulinum toksini bilgi düzeyinin de arttığı gözlenmektedir. Çalışmamızın sonucuna göre tıp fakültesi öğrencilerinin Botulinum toksini hakkındaki bilgi düzeyleri ve farkındalıkları kabul edilebilir seviyededir.

Thanks

The authors would like to thank Professor Fezan Şahin Mutlu for her contribution to statistical analysis. Yazarlar, istatistiksel analize katkılarından dolayı Profesör Fezan Şahin Mutlu'ya teşekkür eder.

References

  • 1. Eisenach JH, Atkinson JLD, Fealey RD. Hyperhidrosis: Evolving Therapies for a Well-Established Phenomenon. Mayo Clin Proc. 2005;80(5):657-666. doi:10.4065/80.5.657
  • 2. Scott AB. Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery. Ophthalmology. 1980;87(10):1044-1049. doi:10.1016/S0161-6420(80)35127-0
  • 3. Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53(3):407-415. doi: 10.1016/j.jaad.2005.06.011
  • 4. Sethi N, Singh S, DeBoulle K, Rahman E. A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications. Aesth Plast Surg. 2021; 45:1210–1220. doi: 10.1007/s00266-020-01983-w
  • 5. Montecucco C, Molgó J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005;5(3):274-279. doi: 10.1016/j.coph.2004.12.006
  • 6. Farag SM, Mohammed MO, EL-Sobky TA, ElKadery NA, ElZohiery AK. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials. JBJS Rev. 2020;8(3): e0119-e0119. doi: 10.2106/JBJS.RVW.19.00119
  • 7. Ade-Hall R, Moore P. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Movement Disorders Group, ed. Cochrane Database Syst Rev. Published online January 24, 2000. doi:10.1002/14651858.CD001408
  • 8. OnabotulinumtoxinA. Professionals AHFS Monographs Print. available from https://www.drugs.com/monograph/onabotulinumtoxina.html
  • 9. Figgitt DP, Noble S. Botulinum Toxin B: A Review of its Therapeutic Potential in the Management of Cervical Dystonia. Drugs. 2002;62(4):705-722. doi:10.2165/00003495-200262040-00011
  • 10. Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: Mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-185. doi:10.1590/S0004-282X2005000100035
  • 11. Uthayasankar D, Priya VV, Gayathri R. Awareness on Botox injection among dental college students in Chennai. J Pharm Res Int. Published online August 26, 2020:64-74. doi:10.9734/jpri/2020/v32i1830691
  • 12. Goldstein, MD SR. Clinical review- Onabotulinum toxin A. Published June 20, 2019. https://www.fda.gov/media/131442/download available from https://www.fda.gov/media/131442/download
  • 13. Instructions for using BOTOX®Liyophilized Powder flacon available from https://pdf.ilacprospektusu.com/6636-botox-liyofilize-toz-iceren-flakon-kt.pdf
  • 14. Dressler D. Subclinical Myasthenia Gravis causing increased sensitivity to botulinum toxin therapy. doi:10.1007/s00702-010-0481-9
  • 15. Timmermans G, Depierreux F, Wang F, Hansen I, Maquet P. Cosmetic injection of botulinum toxin unmasking subclinical myasthenia gravis: a case report and literature review. Case Rep Neurol. 2019;(11):244-251. doi:10.1159/000502350
  • 16. Imam S, Iffat W, Shakeel S, Qamar A, Usman N, Sultana N, Khan FM: Acquaintance of Botox: A cross-sectional survey among female students in Karachi, Pakistan. Afr J Pharm Pharmacol. 2019;13(17):292-296. doi:10.5897/AJPP2019.5060
  • 17. Ministry of Health letter dated 03/08/2015 and numbered 23590821/180/1423 available from https://shgm.saglik.gov.tr/Eklenti/10967/0/botoks-dagitimli-yazi-2pdf.pdf

Eskisehir Osmangazi University Faculty of Medicine Students' Knowledge Levels about Botulinum Toxin: Survey Study

Year 2022, , 336 - 346, 14.03.2022
https://doi.org/10.20515/otd.951150

Abstract

The aim of the study is to evaluate the knowledge and awareness level of medical students through a questionnaire about botulinum toxin, which is widely used in medicine. The correct answer(s) of each question is explained at the end of the questionnaire thus it is aimed to encourage students to learn more about the subject by providing necessary information. The study is a cross-sectional descriptive study conducted by Google survey method to Osmangazi Medical Faculty students in the 2020-2021 academic year. Of the 404 students who responded the survey, 53 were 1st grade, 103 were 2nd grade, 50 were 3rd grade, 64 were 4th grade, 68 were 5th grade and 68 were 6th grade students. The questionnarie contains eight questions and the correct answer to each question is ten points. In questions with more than one correct answer, the weighted average score of each correct answer is calculated by division of ten to the number of correct answers. The total score of the questionnarie is eighty points. The average scores of the first to sixth grades were 38.87, 41.21, 56.75, 56.59, 60.66 and 62.95 respectively. According to the results of our study the level of knowledge of medical students about Botulinum toxin increases with the grade and both the level of knowledge and awareness about Botulinum toxin are at an acceptable level.

References

  • 1. Eisenach JH, Atkinson JLD, Fealey RD. Hyperhidrosis: Evolving Therapies for a Well-Established Phenomenon. Mayo Clin Proc. 2005;80(5):657-666. doi:10.4065/80.5.657
  • 2. Scott AB. Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery. Ophthalmology. 1980;87(10):1044-1049. doi:10.1016/S0161-6420(80)35127-0
  • 3. Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53(3):407-415. doi: 10.1016/j.jaad.2005.06.011
  • 4. Sethi N, Singh S, DeBoulle K, Rahman E. A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications. Aesth Plast Surg. 2021; 45:1210–1220. doi: 10.1007/s00266-020-01983-w
  • 5. Montecucco C, Molgó J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005;5(3):274-279. doi: 10.1016/j.coph.2004.12.006
  • 6. Farag SM, Mohammed MO, EL-Sobky TA, ElKadery NA, ElZohiery AK. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials. JBJS Rev. 2020;8(3): e0119-e0119. doi: 10.2106/JBJS.RVW.19.00119
  • 7. Ade-Hall R, Moore P. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Movement Disorders Group, ed. Cochrane Database Syst Rev. Published online January 24, 2000. doi:10.1002/14651858.CD001408
  • 8. OnabotulinumtoxinA. Professionals AHFS Monographs Print. available from https://www.drugs.com/monograph/onabotulinumtoxina.html
  • 9. Figgitt DP, Noble S. Botulinum Toxin B: A Review of its Therapeutic Potential in the Management of Cervical Dystonia. Drugs. 2002;62(4):705-722. doi:10.2165/00003495-200262040-00011
  • 10. Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: Mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-185. doi:10.1590/S0004-282X2005000100035
  • 11. Uthayasankar D, Priya VV, Gayathri R. Awareness on Botox injection among dental college students in Chennai. J Pharm Res Int. Published online August 26, 2020:64-74. doi:10.9734/jpri/2020/v32i1830691
  • 12. Goldstein, MD SR. Clinical review- Onabotulinum toxin A. Published June 20, 2019. https://www.fda.gov/media/131442/download available from https://www.fda.gov/media/131442/download
  • 13. Instructions for using BOTOX®Liyophilized Powder flacon available from https://pdf.ilacprospektusu.com/6636-botox-liyofilize-toz-iceren-flakon-kt.pdf
  • 14. Dressler D. Subclinical Myasthenia Gravis causing increased sensitivity to botulinum toxin therapy. doi:10.1007/s00702-010-0481-9
  • 15. Timmermans G, Depierreux F, Wang F, Hansen I, Maquet P. Cosmetic injection of botulinum toxin unmasking subclinical myasthenia gravis: a case report and literature review. Case Rep Neurol. 2019;(11):244-251. doi:10.1159/000502350
  • 16. Imam S, Iffat W, Shakeel S, Qamar A, Usman N, Sultana N, Khan FM: Acquaintance of Botox: A cross-sectional survey among female students in Karachi, Pakistan. Afr J Pharm Pharmacol. 2019;13(17):292-296. doi:10.5897/AJPP2019.5060
  • 17. Ministry of Health letter dated 03/08/2015 and numbered 23590821/180/1423 available from https://shgm.saglik.gov.tr/Eklenti/10967/0/botoks-dagitimli-yazi-2pdf.pdf
There are 17 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section ORİJİNAL MAKALE
Authors

Yusuf Coşkun 0000-0001-9764-8257

Aydan Köse 0000-0002-3484-6966

Can Ekinci This is me 0000-0002-5200-3305

Zelal Kaya This is me 0000-0003-0152-3260

Zeki Atahan Uzlaş This is me 0000-0001-8212-0361

Publication Date March 14, 2022
Published in Issue Year 2022

Cite

Vancouver Coşkun Y, Köse A, Ekinci C, Kaya Z, Uzlaş ZA. Eskisehir Osmangazi University Faculty of Medicine Students’ Knowledge Levels about Botulinum Toxin: Survey Study. Osmangazi Tıp Dergisi. 2022;44(3):336-4.


13299        13308       13306       13305    13307  1330126978